Skip to main content

Halozyme Therapeutic (NQ: HALO )

48.86 +0.38 (+0.78%)
Streaming Delayed Price Updated: 12:32 PM EST, Dec 4, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
May 05, 2011
Form SC 13G
Source: SEC/Edgar
April 25, 2011
Form DEF 14A
Source: SEC/Edgar
March 23, 2011
Form 8-K
Source: SEC/Edgar
March 10, 2011
Form 8-K
Source: SEC/Edgar
March 07, 2011
Form 8-K
Source: SEC/Edgar
January 09, 2011
Form 8-K
Source: SEC/Edgar
December 07, 2010
Form 8-K
Source: SEC/Edgar
December 07, 2010
Form 8-K
Source: SEC/Edgar
November 04, 2010
Form 8-K
Source: SEC/Edgar
October 13, 2010
Form 424B5
Source: SEC/Edgar
September 09, 2010
Form 8-K
Source: SEC/Edgar
September 08, 2010
Form 424B5
Source: SEC/Edgar
September 07, 2010
Form 8-K
Source: SEC/Edgar
August 30, 2010
Form 8-K
Source: SEC/Edgar
August 05, 2010
Form 8-K
Source: SEC/Edgar
May 19, 2010
Form 8-K
Source: SEC/Edgar
May 06, 2010
Form ARS
Source: SEC/Edgar
April 01, 2010
Form DEF 14A
Source: SEC/Edgar
March 31, 2010
Form 8-K
Source: SEC/Edgar
March 11, 2010
Form 8-K
Source: SEC/Edgar
March 02, 2010
Form SC 13G/A
Source: SEC/Edgar
February 11, 2010
Form 8-K
Source: SEC/Edgar
February 08, 2010
Form EFFECT
Source: SEC/Edgar
January 20, 2010
Form 8-K
Source: SEC/Edgar
January 10, 2010
Form S-3
Source: SEC/Edgar
January 04, 2010
Form 8-K
Source: SEC/Edgar
November 05, 2009
Form 8-K
Source: SEC/Edgar
October 01, 2009
Form 8-K
Source: SEC/Edgar
August 06, 2009
Form 424B5
Source: SEC/Edgar
June 22, 2009
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.